Mr. Bier is a communications and strategy expert who has played a key role in building brands
Mr. Bier is a communications and strategy expert who has played a key role in building brands
This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
The mental healthcare industry is ripe for innovation. And companies like Mind Cure (CSE: MCUR), which recently completed its IPO, are set to lead the way.
Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Field Trip Psychedelics is targeting a $16 billion treatment market with its ketamine-assisted psychotherapy clinics.
Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor
The world-renowned transformative medicine expert will contribute towards Mind Cure's work in the realm of psychedelic research, treatment and integration
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
With trading volumes going through the roof and a potential NASDAQ listing, will MindMed be the next billion-dollar psychedelics company?
Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now